January 2017 FDA Recall Alfuzosin Hydrochloride by Sun Pharmaceutical Industries, Inc.
D-0502-2017 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by Sun Pharmaceutical Industries, Inc. on January 5, 2017 for the product Alfuzosin Hydrochloride. The FDA reported the reason for recall as presence of foreign substance. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0502-2017

Reason for Recall
Presence of Foreign Substance: consumer complaint for foreign matter embedded in the tablet identified as a broken piece of wire rope from the manufacturing equipment.
Initiated
01-05-2017
Reported
03-08-2017
Quantity
22,915 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Sun Pharmaceutical Industries, Inc.
Nationwide in the USA and Puerto Rico.
Alfuzosin Hydrochloride Extended-release Tablets, 10 mg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512; Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389, Gujarat, India, NDC 47335-956-88.

Batch or Lot Expiration Information

Lot# : JKR5219A, JKR5200A, JKR5220A, JKR5221A, JKR5222A, Exp 03/18